Experimental studies in glioma models revealed that SIRT6 overexpression suppresses tumor growth by promoting histone deacetylation and cell-cycle arrest, whereas SIRT1 limits androgen biosynthesis through FOXO1 deacetylation, thereby restraining tumor progression (84, 86). Here, SIRT6 is linked to neoplasm.